TuisME • NASDAQ
add
23andMe Holding Co.
Vorige sluiting
$3,23
Dagwisseling
$2,99 - $3,21
Jaarwisseling
$2,66 - $20,20
Markkapitalisasie
74,94 m USD
Gemiddelde volume
404,88 k
P/V-verhouding
-
Dividend-opbrengs
-
Primêre beurs
NASDAQ
In die nuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Inkomste | 44,07 m | -11,86% |
Bedryfskoste | 81,33 m | -17,18% |
Netto inkomste | -59,10 m | 21,48% |
Netto winsgrens | -134,11 | 10,91% |
Wins per aandeel | — | — |
EBITDA | -54,96 m | 21,06% |
Effektiewe belastingkoers | 0,07% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Kontant en korttermynbeleggings | 126,60 m | -50,62% |
Totale bates | 318,94 m | -60,19% |
Totale aanspreeklikheid | 217,01 m | 23,31% |
Totale ekwiteit | 101,93 m | — |
Uitstaande aandele | 26,12 m | — |
Prys om te bespreek | 0,82 | — |
Opbrengs op bates | -42,89% | — |
Opbrengs op kapitaal | -75,30% | — |
Kontantvloei
Netto kontantverandering
(USD) | Sep. 2024info | J/J-verandering |
---|---|---|
Netto inkomste | -59,10 m | 21,48% |
Kontant van bedrywe | -40,93 m | 28,34% |
Kontant van beleggings | -2,70 m | 2,63% |
Kontant van finansiering | 260,00 k | -83,68% |
Netto kontantverandering | -43,37 m | 25,18% |
Beskikbare kontantvloei | -12,82 m | 59,90% |
Meer oor
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, to generate reports relating to the customer's ancestry and genetic predispositions to health-related topics. The company's name is derived from the 23 pairs of chromosomes in a diploid human cell.
Founded in 2006, 23andMe soon became the first company to begin offering autosomal DNA testing for ancestry, which all other major companies now use. Its saliva-based direct-to-consumer genetic testing business was named "Invention of the Year" by Time in 2008.
The company had a previously fraught relationship with the United States Food and Drug Administration due to its genetic health tests; as of October 2015, DNA tests ordered in the US include a revised health component, per FDA approval. 23andMe has been selling a product with both ancestry and health-related components in Canada since October 2014, and in the UK since December 2014. Wikipedia
Gestig
Apr. 2006
Webwerf
Werknemers
571